跳至主要内容
临床试验/NL-OMON23321
NL-OMON23321已完成不适用

Effects of aspirin on markers of inflammation and coagulation in subclinical atherosclerosis in type 2 diabetic subjects.

eiden University Medical Center (LUMC), department of General Internal Medicine0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40

研究概览

简要总结

  1. J Thromb Haemost. 2007 Jul;5(7):1562-4. Epub 2007 Apr 19.
    2. Diabetes Obes Metab. 2008 Aug;10(8):668-74. Epub 2007 Nov 22.

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Diabetes mellitus type 2;
  • 2. Age >18 year;

排除标准

  • 1. History of myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, proven manifest coronary artery disease, angina pectoris, heart failure or severe cardiac arrhythmia;
  • 2. History of cerebrovascular accident, transient ischemic attack;

研究者

发起方
eiden University Medical Center (LUMC), department of General Internal Medicine

相似试验